Titre : Jumonji Domain-Containing Histone Demethylases

Jumonji Domain-Containing Histone Demethylases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Avoidance Learning
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Jumonji Domain-Containing Histone Demethylases : Questions médicales les plus fréquentes", "headline": "Jumonji Domain-Containing Histone Demethylases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Jumonji Domain-Containing Histone Demethylases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-10", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Jumonji Domain-Containing Histone Demethylases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dioxygenases", "url": "https://questionsmedicales.fr/mesh/D049308", "about": { "@type": "MedicalCondition", "name": "Dioxygenases", "code": { "@type": "MedicalCode", "code": "D049308", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.416" } } }, "about": { "@type": "MedicalCondition", "name": "Jumonji Domain-Containing Histone Demethylases", "alternateName": "Jumonji Domain-Containing Histone Demethylases", "code": { "@type": "MedicalCode", "code": "D056484", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Danica Galonić Fujimori", "url": "https://questionsmedicales.fr/author/Danica%20Galoni%C4%87%20Fujimori", "affiliation": { "@type": "Organization", "name": "Department of Cellular and Molecular Pharmacology, University of California San Francisco; San Francisco, CA 94158, USA; Department of Pharmaceutical Chemistry, University of California San Francisco; San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco; San Francisco, CA 94158, USA. Electronic address: danica.fujimori@ucsf.edu." } }, { "@type": "Person", "name": "James E Longbotham", "url": "https://questionsmedicales.fr/author/James%20E%20Longbotham", "affiliation": { "@type": "Organization", "name": "Department of Cellular and Molecular Pharmacology, University of California San Francisco, 600 16th Street, Genentech Hall, San Francisco, California 94158, United States." } }, { "@type": "Person", "name": "Feng Li", "url": "https://questionsmedicales.fr/author/Feng%20Li", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology, Key Laboratory of Cell Biology, National Health Commission of the PRC, Shenyang, China." } }, { "@type": "Person", "name": "Christopher J Schofield", "url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield", "affiliation": { "@type": "Organization", "name": "Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , United Kingdom." } }, { "@type": "Person", "name": "Anthony Tumber", "url": "https://questionsmedicales.fr/author/Anthony%20Tumber", "affiliation": { "@type": "Organization", "name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford 12 Mansfield Road OX1 3TA Oxford UK christopher.schofield@chem.ox.ac.uk lennart.brewitz@chem.ox.ac.uk." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Experiential Avoidance During Mealtimes Among Individuals With Eating Disorders.", "datePublished": "2024-04-10", "url": "https://questionsmedicales.fr/article/39174267", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.beth.2024.04.001" } }, { "@type": "ScholarlyArticle", "name": "Increased positive affect is associated with less generalization of pain-related avoidance.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36174262", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.brat.2022.104199" } }, { "@type": "ScholarlyArticle", "name": "Quantifying aberrant approach-avoidance conflict in psychopathology: A review of computational approaches.", "datePublished": "2023-02-17", "url": "https://questionsmedicales.fr/article/36804398", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neubiorev.2023.105103" } }, { "@type": "ScholarlyArticle", "name": "Microtemporal Relationships in the Fear Avoidance Model: An Ecological Momentary Assessment Study.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/35866559", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/AJP.0000000000001058" } }, { "@type": "ScholarlyArticle", "name": "Body image perceptions and avoidance behaviours among a Moroccan group of adolescents.", "datePublished": "2022-05-20", "url": "https://questionsmedicales.fr/article/35499239", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/03014460.2022.2072524" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "Oxygénases", "item": "https://questionsmedicales.fr/mesh/D010105" }, { "@type": "ListItem", "position": 6, "name": "Dioxygenases", "item": "https://questionsmedicales.fr/mesh/D049308" }, { "@type": "ListItem", "position": 7, "name": "Jumonji Domain-Containing Histone Demethylases", "item": "https://questionsmedicales.fr/mesh/D056484" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Jumonji Domain-Containing Histone Demethylases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Jumonji Domain-Containing Histone Demethylases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Jumonji Domain-Containing Histone Demethylases", "description": "Comment diagnostiquer une dysfonction des Jumonji ?\nQuels marqueurs biologiques sont associés aux Jumonji ?\nLes biopsies sont-elles utiles pour le diagnostic ?\nQuels tests sanguins sont recommandés ?\nY a-t-il des tests d'imagerie pour ces enzymes ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Jumonji Domain-Containing Histone Demethylases", "description": "Quels symptômes sont liés aux anomalies des Jumonji ?\nLes troubles neurologiques sont-ils associés ?\nY a-t-il des symptômes cutanés associés ?\nLes symptômes varient-ils selon le type de Jumonji ?\nLes symptômes sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Jumonji Domain-Containing Histone Demethylases", "description": "Peut-on prévenir les dysfonctionnements des Jumonji ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nY a-t-il des vaccins pour prévenir ces dysfonctionnements ?\nL'éducation génétique est-elle importante ?\nLes conseils diététiques peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Jumonji Domain-Containing Histone Demethylases", "description": "Quels traitements sont disponibles pour les dysfonctionnements des Jumonji ?\nLes médicaments peuvent-ils cibler les Jumonji ?\nY a-t-il des traitements naturels recommandés ?\nLes traitements sont-ils personnalisés ?\nLes thérapies combinées sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Jumonji Domain-Containing Histone Demethylases", "description": "Quelles complications peuvent survenir avec les dysfonctionnements des Jumonji ?\nLes complications sont-elles graves ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles réversibles ?\nLes complications varient-elles selon le type de Jumonji ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Jumonji Domain-Containing Histone Demethylases", "description": "Quels sont les facteurs de risque pour les dysfonctionnements des Jumonji ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Avoidance+Learning&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des Jumonji ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux Jumonji ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de méthylation des histones et l'expression des gènes sont des marqueurs clés." } }, { "@type": "Question", "name": "Les biopsies sont-elles utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent aider à évaluer l'expression des Jumonji dans les tissus." } }, { "@type": "Question", "name": "Quels tests sanguins sont recommandés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests pour mesurer les niveaux de protéines associées aux Jumonji peuvent être effectués." } }, { "@type": "Question", "name": "Y a-t-il des tests d'imagerie pour ces enzymes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne permet pas de diagnostiquer directement les Jumonji." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux anomalies des Jumonji ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de croissance, des anomalies développementales et des cancers peuvent survenir." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils associés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements neurologiques peuvent être liés à des mutations des Jumonji." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies cutanées peuvent être observées, notamment dans des syndromes spécifiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de Jumonji ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types de Jumonji peuvent entraîner des symptômes variés selon leur fonction." } }, { "@type": "Question", "name": "Les symptômes sont-ils réversibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité et de la nature de la dysfonction des Jumonji." } }, { "@type": "Question", "name": "Peut-on prévenir les dysfonctionnements des Jumonji ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les individus à risque de dysfonctionnements." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces dysfonctionnements ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les dysfonctionnements des Jumonji." } }, { "@type": "Question", "name": "L'éducation génétique est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur les risques génétiques peut aider à la prévention et à la détection précoce." } }, { "@type": "Question", "name": "Les conseils diététiques peuvent-ils aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé cellulaire, mais ne prévient pas directement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dysfonctionnements des Jumonji ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours d'étude." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils cibler les Jumonji ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments expérimentaux ciblent les Jumonji pour traiter des cancers." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels recommandés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches nutritionnelles et phytothérapeutiques sont explorées, mais peu prouvées." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des mutations spécifiques des Jumonji." } }, { "@type": "Question", "name": "Les thérapies combinées sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que les thérapies combinées peuvent améliorer les résultats cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les dysfonctionnements des Jumonji ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des cancers, des troubles métaboliques et des anomalies développementales peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être potentiellement mortelles si non traitées." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications chroniques peuvent se développer, affectant la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Les complications varient-elles selon le type de Jumonji ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent varier en fonction du type de Jumonji impliqué." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les dysfonctionnements des Jumonji ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains dysfonctionnements des Jumonji sont plus fréquents avec l'âge." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut augmenter le risque de dysfonctionnements." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut accroître le risque de dysfonctionnements des Jumonji." } } ] } ] }

Sources (10000 au total)

Microtemporal Relationships in the Fear Avoidance Model: An Ecological Momentary Assessment Study.

Current literature in pediatric pain evaluates the Fear Avoidance model (FAM) pathways at the trait (or macrotemporal) level, but it is unknown if these pathways also occur at the state (or microtempo... 71 pediatric patients with chronic abdominal pain ( M =13.34 y, SD=2.67 y) reported pain severity, pain-related fear, and avoidance via ecological momentary assessments over 14 days.... Our results indicated significant microtemporal relationships between Fear Avoidance constructs for pain predicting pain-related fear, pain-related fear predicting avoidance, and avoidance predicting ... The current study suggests that the ways in which the FAM is related to various aspects of pain functioning differs on a state-level, which adds new clinical and research opportunities....

Body image perceptions and avoidance behaviours among a Moroccan group of adolescents.

Adolescents are a vulnerable group to body dissatisfaction that causes unhealthy attitudes and behaviours. It has been shown that many factors affect body image dissatisfaction.... To describe body image size perception, degree of body dissatisfaction, avoidance behaviours, and their relationship with gender, age, and weight status, and to assess the relationship between body di... This cross-sectional survey was comprised of a sample of 487 adolescents. Stunkard's Figure Rating Scale was used to assess perceptions of current and ideal body image and body dissatisfaction. Body I... Body dissatisfaction was found to be strongly associated with weight status in both male and female adolescents. Avoidance behaviours were positively associated with gender, age, weight status, and bo... Weight status is an important factor that deeply impacts adolescent body dissatisfaction. Adolescents resort to behaviour avoidance and physical appearance control to cope with body dissatisfaction....

Psychometric properties of the chinese version of multidimensional experiential avoidance questionnaire-30.

Experiential avoidance represents the tendency to avoid negative internal experiences, which is a key concept in Acceptance and Commitment Therapy. However, existing measures of experiential avoidance... Two questionnaire surveys were conducted. The first sample (N = 546) was analyzed using classical test theory (CTT), and the second sample (N = 511) was analyzed using multidimensional item response t... CTT supported the six-factor structure of MEAQ-30, indicating good internal consistency and measurement invariance across genders. Furthermore, the Chinese version of MEAQ-30 showed satisfactory conve... The Chinese version of MEAQ-30 has good reliability and validity and is suitable for assessing experiential avoidance among Chinese populations....

Validation of the Brief Experiential Avoidance Questionnaire (BEAQ) in a representative Polish sample.

The study aimed to validate the Brief Experiential Avoidance Questionnaire (BEAQ) in Polish and establish its psychometric properties.... A representative sample of the Polish population (N = 1,216) in terms of gender, age, education, and place of residence participated in the online study. The adaptation was conducted with back transla... Confirmatory factor analysis showed that the unidimensional model insufficiently fit the data, similarly to other reports on BEAQ validations. Exploratory factor analysis using oblimin rotation extrac... The Polish BEAQ validation demonstrates it is a tool that can be successfully used in research and clinical practice as it provides a reliable measure of experiential avoidance and is convenient thank...

Preventive and Avoidant Behaviors Followed by Jordanians During COVID-19 Pandemic.

During the coronavirus disease 2019 (COVID-19), individuals' compliance with protective behaviors was the most effective strategy to break the infection chain and prevent disease spread, even with vac... A cross-sectional study with an exploratory, descriptive design was used to collect data using an online self-reported questionnaire from Jordanian people. The survey included the Protection from Infe... A total sample of 1053 Jordanian citizens was included in the study. The participants exhibited a moderate level of self-care behaviors and high levels of protective and infection avoidance behaviors.... During pandemics, policy-makers must understand public concerns and protective behaviors, then provide them with tailored education through health promotion campaigns to enhance healthy behaviors....